Patents by Inventor DAINIPPON SUMITOMO PHARMA CO., LTD.

DAINIPPON SUMITOMO PHARMA CO., LTD. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Imidazoquinolines with Immuno-Modulating Properties
    Publication number: 20130225555
    Abstract: The present invention provides compounds of formula (I) wherein Ra, R1, R2, R3, X1, Y1, Z1, A, n and m are as defined in the specification, and pharmaceutically acceptable salts thereof, as well as processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: March 14, 2013
    Publication date: August 29, 2013
    Applicants: Dainippon Sumitomo Pharma Co., Ltd., AstraZeneca AB
    Inventors: AstraZeneca AB, Dainippon Sumitomo Pharma Co., Ltd.
  • HUMAN MONOCLONAL ANTIBODY
    Publication number: 20130196378
    Abstract: The present invention provides an anti-CD81 antibody usable as a pharmaceutical product for human. Specifically, the present invention provides an anti-human CD81 antibody capable of binding to a peptide region consisting of the amino acid sequence of the amino acid numbers 80 to 175 in the amino acid sequence shown in SEQ ID NO:22.
    Type: Application
    Filed: March 15, 2013
    Publication date: August 1, 2013
    Applicant: DAINIPPON SUMITOMO PHARMA CO., LTD.
    Inventor: DAINIPPON SUMITOMO PHARMA CO., LTD.